OpenAlex
PricingAboutJobs
Log inGet started
Work

The Antidiabetogenic Effect of GLP-1 Is Maintained During a 7-Day Treatment Period and Improves Diabetic Dyslipoproteinemia in NIDDM Patients

HTML

Year: 1996
Type: article
Study design: Clinical Trial
Source: Diabetes Care
DOI: 10.2337/diacare.19.11.1200
Authors: Lisa Juntti-Berggren, Jan Pigon, Fredrik Karpe, Anders Hamsten, Mark Gutniak, Louis Vignati, Suad Efendic
Institutions: Karolinska University Hospital, Karolinska Institutet, Eli Lilly (United States)
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: glucagon-like peptide-1, type 2 diabetes, insulin dose reduction, postprandial blood glucose, VLDL triglycerides, LDL particle size, lipoprotein lipase, hepatic lipase, intensive insulin therapy, lipoprotein metabolism
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2073099528
FWCI: 3.62
Cites:
Cited by: 66
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security